Inspire Pharma Pays $5.9M To End FCA Suit Over Eye Drug
Inspire Pharmaceuticals Inc. agreed to pay $5.9 million to settle a False Claims Act suit accusing the former unit of Merck & Co. Inc. of fraudulently marketing a drug used to...To view the full article, register now.
Already a subscriber? Click here to view full article